SecProbe.io

Filing text and metadata
Intelligence Terminal Search Topics Monthly Activity About

Correspondence 0001213900-22-074970 from Pivotal Investment Corp III (CIK 0001835800)

Pivotal Investment Corp III (CIK 0001835800)
Date: Nov. 23, 2022 · CIK: 0001835800 · Accession: 0001213900-22-074970

AI Filing Summary & Sentiment

File numbers found in text: 001-40019

Referenced dates: November 23, 2022

Date
November 23, 2022
Author
/s/ Jeffrey M. Gallant
Form
CORRESP
Company
Pivotal Investment Corp III (CIK 0001835800)

Letter

Securities and Exchange Commission Division of Corporation Finance Office of Real Estate & Construction Re: Pivotal Investment Corporation III Preliminary Proxy Statement on Schedule 14A Filed November 22, 2022 File No.: 001-40019

Dear Ladies and Gentlemen:

On behalf of Pivotal Investment Corporation III (“Company”), we respond as follows to the Staff’s comment letter, dated November 23, 2022, relating to the above-captioned Preliminary Proxy Statement (“Proxy Statement”).

Please note that for the Staff’s convenience, we have recited the Staff’s comment and provided the Company’s response to such comment immediately thereafter.

Schedule 14A filed November 22, 2022

General

1. With a view toward disclosure, please tell us whether your sponsor is, is controlled by, has any members who are, or has substantial ties with, a non-U.S. person. Also revise your filing to include risk factor disclosure that addresses how this fact could impact your ability to complete your initial business combination. For instance, discuss the risk to investors that you may not be able to complete an initial business combination with a target company should the transaction be subject to review by a U.S. government entity, such as the Committee on Foreign Investment in the United States (CFIUS), or ultimately prohibited. Disclose that as a result, the pool of potential targets with which you could complete an initial business combination may be limited. Further, disclose that the time necessary for government review of the transaction or a decision to prohibit the transaction could prevent you from completing an initial business combination and require you to liquidate. Disclose the consequences of liquidation to investors, such as the losses of the investment opportunity in a target company, any price appreciation in the combined company, and the warrants, which would expire worthless.

We wish to advise the Staff that the Company’s sponsor is not, is not controlled by, does not have any members who are, and has no substantial ties with, a non-U.S. person. Accordingly, we have not revised the disclosure in the Proxy Statement in response to this comment.

* * * * * * * * * *

If you have any questions, please do not hesitate to contact me at the above telephone and facsimile numbers.

Sincerely,
/s/ Jeffrey M. Gallant

Show Raw Text
CORRESP
1
filename1.htm

    Graubard Miller

    The Chrysler Building

    405 Lexington Avenue

    New York, N.Y.
    10174-4499

    (212) 818-8800

    (212) 818-8881

    (212) 818-8638

    email address

    jgallant@graubard.com

November 23, 2022

Securities and Exchange Commission

Division of Corporation Finance

Office of Real Estate & Construction

100 F Street, N.E.

Washington, D.C. 20549

    Re:
    Pivotal Investment Corporation III

    Preliminary Proxy Statement on Schedule 14A

    Filed November 22, 2022

    File No.: 001-40019

Dear Ladies and Gentlemen:

On behalf of Pivotal Investment Corporation
III (“Company”), we respond as follows to the Staff’s comment letter, dated November 23, 2022, relating to the above-captioned
Preliminary Proxy Statement (“Proxy Statement”).

Please note that for the Staff’s convenience,
we have recited the Staff’s comment and provided the Company’s response to such comment immediately thereafter.

Schedule 14A filed November
22, 2022

 General

 1. With a view toward disclosure, please tell us whether your sponsor is, is controlled by, has any members who are, or has substantial
ties with, a non-U.S. person. Also revise your filing to include risk factor disclosure that addresses how this fact could impact your
ability to complete your initial business combination. For instance, discuss the risk to investors that you may not be able to complete
an initial business combination with a target company should the transaction be subject to review by a U.S. government entity, such as
the Committee on Foreign Investment in the United States (CFIUS), or ultimately prohibited. Disclose that as a result, the pool of potential
targets with which you could complete an initial business combination may be limited. Further, disclose that the time necessary for government
review of the transaction or a decision to prohibit the transaction could prevent you from completing an initial business combination
and require you to liquidate. Disclose the consequences of liquidation to investors, such as the losses of the investment opportunity
in a target company, any price appreciation in the combined company, and the warrants, which would expire worthless.

We wish to advise the Staff that the Company’s
sponsor is not, is not controlled by, does not have any members who are, and has no substantial ties with, a non-U.S. person. Accordingly,
we have not revised the disclosure in the Proxy Statement in response to this comment.

* * * * * * * * * *

If you have any questions, please do not hesitate to
contact me at the above telephone and facsimile numbers.

Sincerely,

/s/ Jeffrey M. Gallant

Jeffrey M. Gallant

 cc: Mr. Kevin Griffin